Target Name: RASGEF1C
NCBI ID: G255426
Review Report on RASGEF1C Target / Biomarker Content of Review Report on RASGEF1C Target / Biomarker
RASGEF1C
Other Name(s): RasGEF domain family member 1C (RASGEF1C) | RGF1C_HUMAN | Ras-GEF domain-containing family member 1C | ras-GEF domain-containing family member 1C | RasGEF domain family member 1C

The RasGEF1C Domain: Versatile Regulator of Cellular Signaling Pathways

The RasGEF1C (Ras-associated G protein-coupled receptor 1C) domain is a protein that is found in many different cell types in the human body. It is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play important roles in cellular signaling. The RasGEF1C domain is responsible for the function of many different proteins, including some that are involved in diseases such as cancer, diabetes, and cardiovascular disease.

One of the key functions of the RasGEF1C domain is its role in cell signaling. It is a key component of the intracellular signaling pathway known as the RAS/MAPK pathway, which is involved in many different cellular processes, including cell growth, differentiation, and survival. The RASGEF1C domain is part of the RAS gene, which is a gene that is involved in the production of the RAS protein. The RAS protein is a key signaling molecule that is involved in many different cellular processes, including the regulation of cell growth , differentiation, and survival.

The RasGEF1C domain is also involved in many different cellular signaling pathways. For example, it is involved in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. which is the process by which cells move from one location to another in the body. The RasGEF1C domain is part of the Focal Adhesion Protein (FAP) gene, which is a gene that is involved in the regulation of cell adhesion.

In addition to its role in cell signaling, the RasGEF1C domain is also involved in the regulation of many different cellular processes. For example, it is involved in the regulation of cell proliferation, which is the process by which cells grow and divide. It is also involved in the regulation of cell differentiation, which is the process by which cells become different types of cells. The RasGEF1C domain is part of the transcription factor-like 3 (TAL1) gene, which is a gene that is involved in the regulation of cell proliferation.

The RasGEF1C domain is also involved in the regulation of many different cellular processes that are not well understood. For example, it is involved in the regulation of cell death, which is the process by which cells die. cell signaling pathways that are not well understood, including the regulation of cell-cell communication and the regulation of inflammation.

In conclusion, the RasGEF1C domain is a protein that is involved in many different cellular processes in the human body. It is a key component of the RAS/MAPK pathway and the FAP gene, which are involved in cell signaling and cell adhesion. It is also involved in the regulation of cell proliferation, differentiation, and cell death, as well as many other cellular processes that are not well understood. As a result, the RasGEF1C domain is a potential drug target and a biomarker for many different diseases.

Protein Name: RasGEF Domain Family Member 1C

Functions: Guanine nucleotide exchange factor (GEF)

The "RASGEF1C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASGEF1C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RASGRF1 | RASGRF2 | RASGRP1 | RASGRP2 | RASGRP3 | RASGRP4 | RASIP1 | RASL10A | RASL10B | RASL11A | RASL11B | RASL12 | RASSF1 | RASSF10 | RASSF2 | RASSF3 | RASSF4 | RASSF5 | RASSF6 | RASSF7 | RASSF8 | RASSF8-AS1 | RASSF9 | RAVER1 | RAVER2 | RAX | RAX2 | RB1 | RB1-DT | RB1CC1 | RBAK | RBAK-RBAKDN | RBAKDN | RBBP4 | RBBP4P2 | RBBP4P6 | RBBP5 | RBBP6 | RBBP7 | RBBP8 | RBBP8NL | RBBP9 | RBCK1 | RBFA | RBFOX1 | RBFOX2 | RBFOX3 | RBIS | RBKS | RBL1 | RBL2 | RBM10 | RBM11 | RBM12 | RBM12B | RBM14 | RBM14-RBM4 | RBM15 | RBM15-AS1 | RBM15B | RBM17 | RBM17P1 | RBM18 | RBM19 | RBM20 | RBM22 | RBM22P1 | RBM23 | RBM24 | RBM25 | RBM26 | RBM26-AS1 | RBM27 | RBM28 | RBM3 | RBM33 | RBM34 | RBM38 | RBM39 | RBM4 | RBM41 | RBM42 | RBM43 | RBM43P1 | RBM44 | RBM45 | RBM46 | RBM47 | RBM48 | RBM48P1 | RBM4B | RBM5 | RBM5-AS1 | RBM6 | RBM7 | RBM8A | RBMS1 | RBMS1P1 | RBMS2 | RBMS2P1